Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

BACKGROUND: The systemic administration of cytotoxic chemotherapeutic agents for cancer treatment often has toxic side effects, limiting the usage dose. To increase chemotherapeutic efficacy while reducing toxic effects, a rational design for synergy-based drug regimens is essential. This study inve...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nanobiotechnology
Glavni autori: Alemi, Ashraf, Zavar Reza, Javad, Haghiralsadat, Fateme, Zarei Jaliani, Hossein, Haghi Karamallah, Mojtaba, Hosseini, Seyed Ahmad, Haghi Karamallah, Somayeh
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865280/
https://ncbi.nlm.nih.gov/pubmed/29571289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-018-0351-4
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items